Newron Pharmaceuticals S.p.A. logo

Newron Pharmaceuticals S.p.A. (NWRN)

Market Closed
8 Dec, 15:20
SIX SIX
19. 38
CHF
+1.1
+6.02%
CHF
129.49M Market Cap
- P/E Ratio
0% Div Yield
338,370 Volume
-0.44 Eps
18.28 CHF
Previous Close
Day Range
18.12 20.2
Year Range
5.2 20.2
Want to track NWRN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Newron Pharmaceuticals S.p.A. logo
NWRN Newron Pharmaceuticals S.p.A.
17 Apr 2025
-
-
Newron Pharmaceuticals S.p.A. logo
NWRN Newron Pharmaceuticals S.p.A.
19 Sep 2024
-
-
Newron Pharmaceuticals S.p.A. logo
NWRN Newron Pharmaceuticals S.p.A.
17 Apr 2024
-
-
Newron Pharmaceuticals S.p.A. logo
NWRN Newron Pharmaceuticals S.p.A.
14 Mar 2024
-
-
Newron Pharmaceuticals S.p.A. logo
NWRN Newron Pharmaceuticals S.p.A.
15 Sep 2016
-
-
Newron Pharmaceuticals S.p.A. logo
NWRN Newron Pharmaceuticals S.p.A.
22 Mar 2016
-
-

NWRN Earnings Reports FAQ

What is the earnings per share (EPS) for NWRN?

The current EPS is -0.44.

What is the company's earnings growth rate?

Newron Pharmaceuticals S.p.A has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Newron Pharmaceuticals S.p.A has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Newron Pharmaceuticals S.p.A are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for NWRN at this time, as Newron Pharmaceuticals S.p.A has no recent EPS data to calculate it.